乳腺癌通过降低细胞硬度/增加癌周基质的方式促进其穿过狭窄孔隙并增强转移能力的机制分析

国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
既往研究认为,肿瘤细胞通过狭窄孔隙的极限是约3.0um,而更小的孔隙则不能通过。本课题组设计了一种乳腺癌连续转移模型,鉴定出一系列侵袭性更强的乳腺癌细胞,并利用体外细胞三维培养模型、发现这些细胞能够利用癌周基质通过0.8um的孔隙,远超过了之前认为的肿瘤细胞能通过的下限。我们发现:在转移过程中,乳腺癌细胞须挤压自身才能穿过基底膜中的狭窄孔道,在这种机械压力刺激下,细胞可能通过减少I、III、V型胶原的分泌降低自身硬度,从而有利于细胞用更剧烈的形变来穿过孔隙;另一方面,通过增加IV型胶原合成,使癌周基质增多,形成足够多的孔道和攀附结构,有利于变软的癌细胞持续通过其间向周边侵袭。下一步我们拟通过微流控和活细胞动态观察等技术,探索影响乳腺癌细胞穿过微小孔隙的极限,并分析其关键分子机制。我们的研究有可能提供一个新的理论模型来解释触发和调控肿瘤细胞硬度和穿越狭窄孔隙的分子机制,具有重要的科学价值。
英文摘要
According to previous studies, cancer cells are unable to penetrate tissues through tight interstitial spaces with a diameter smaller than 3.0um. In this study, we established a continuous metastasis model of breast cancer, by which we screened a series of more aggressive and metastatic breast cancer cells. To our surprise, these cells were able to migrate through 0.8um pores with the presence of extracellular matrix (ECM), which is much smaller than the diameter of 3.0um. Our data suggests that during the metastatic process, breast cancer cells must squeeze themselves through the narrow pores in the basement membrane. Under this mechanical stress, the cells may reduce their stiffness by decreasing the secretion of collagen types I, III, and V. Therefore, the softer cells can squeeze themselves to penetrate through the confined tissue spaces. On the other hand, the cell may increase the secretion of type IV collagen to produce more extracellular matrix, which provides sufficient pores and climbing structures for the softer cells to pass through. In the present study, we seek to explore the very limit of the pores size for the breast cancer cells to migrate through by using the microfluidic device and dynamic live cell observation techniques, and clarify the underlying mechanism. Our study may provide a novel model to explain the molecular mechanisms that trigger and regulate the cancer cell stiffness and how they penetrate confined tissue spaces.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence.
舒尼替尼通过诱导内皮细胞衰老促进转移性乳腺癌扩散
DOI:10.1186/s13058-020-01346-y
发表时间:2020-09-29
期刊:Breast cancer research : BCR
影响因子:--
作者:Wang D;Xiao F;Feng Z;Li M;Kong L;Huang L;Wei Y;Li H;Liu F;Zhang H;Zhang W
通讯作者:Zhang W
Intermedin promotes vessel fusion by inducing VE-cadherin accumulation at potential fusion sites and to achieve a dynamic balance between VE-cadherin-complex dissociation/reconstitution.
Intermedin 通过诱导 VE-钙粘蛋白在潜在融合位点积累来促进血管融合,并实现 VE-钙粘蛋白-复合物解离/重建之间的动态平衡
DOI:10.1002/mco2.9
发表时间:2020-06
期刊:MedComm
影响因子:9.9
作者:Kong L;Xiao F;Wang L;Li M;Wang D;Feng Z;Huang L;Wei Y;Li H;Liu F;Kang Y;Liao X;Zhang W
通讯作者:Zhang W
Inhibition of Intermedin (Adrenomedullin 2) Suppresses the Growth of Glioblastoma and Increases the Antitumor Activity of Temozolomide
抑制 Intermedin(肾上腺髓质素 2)可抑制胶质母细胞瘤的生长并增加替莫唑胺的抗肿瘤活性
DOI:10.1158/1535-7163.mct-20-0619
发表时间:2021-02-01
期刊:MOLECULAR CANCER THERAPEUTICS
影响因子:5.7
作者:Huang, Luping;Wang, Denian;Zhang, Wei
通讯作者:Zhang, Wei
DOI:10.3389/fimmu.2021.755579
发表时间:2021
期刊:Frontiers in immunology
影响因子:7.3
作者:Zhou Y;Liao X;Song X;He M;Xiao F;Jin X;Xie X;Zhang Z;Wang B;Zhou C;Kang Y;Zhang W
通讯作者:Zhang W
Intermedin facilitates hepatocellular carcinoma cell survival and invasion via ERK1/2-EGR1/DDIT3 signaling cascade.
Intermedin 通过 ERK1/2-EGR1/DDIT3 信号级联促进肝细胞癌细胞存活和侵袭
DOI:10.1038/s41598-020-80066-x
发表时间:2021-01-12
期刊:Scientific reports
影响因子:4.6
作者:Xiao F;Li H;Feng Z;Huang L;Kong L;Li M;Wang D;Liu F;Zhu Z;Wei Y;Zhang W
通讯作者:Zhang W
脱落微囊泡重新融合为完整细胞——肿瘤细胞穿过微小组织间隙的一种新机制
- 批准号:--
- 项目类别:面上项目
- 资助金额:55.7万元
- 批准年份:2021
- 负责人:张巍
- 依托单位:
Intermedin(IMD)促进血管融合的分子机制研究
- 批准号:81372144
- 项目类别:面上项目
- 资助金额:70.0万元
- 批准年份:2013
- 负责人:张巍
- 依托单位:
阻断Intermedin活性介导的抗肿瘤新生血管生成作用研究
- 批准号:30801374
- 项目类别:青年科学基金项目
- 资助金额:20.0万元
- 批准年份:2008
- 负责人:张巍
- 依托单位:
国内基金
海外基金
